Molecular sampling of prostate cancer: a dilemma for predicting disease progression

Molecular sampling of prostate cancer: a dilemma for predicting disease progression

Show other versions (1)

<p>Abstract</p> <p>Background</p> <p>Current prostate cancer prognostic models are based on pre-treatment prostate specific antigen (PSA) levels, biopsy Gleason score, and clinical staging but in practice are inadequate to accurately predict disease progression. Hence,...

Full description

Bibliographic Details
Main Authors: Mucci Lorelei A, Fall Katja, Adami Hans-Olov, Perner Sven, Hoshida Yujin, Setlur Sunita R, Pawitan Yudi, Calza Stefano, Demichelis Francesca, Sboner Andrea, Kantoff Philip W, Stampfer Meir, Andersson Swen-Olof, Varenhorst Eberhard, Johansson Jan-Erik, Gerstein Mark B, Golub Todd R, Rubin Mark A, Andrén Ove
Format: Article
Language:English
Published: BMC 2010-03-01
Series:BMC Medical Genomics
Online Access:http://www.biomedcentral.com/1755-8794/3/8

Internet

http://www.biomedcentral.com/1755-8794/3/8

Similar Items